1. Home
  2. GERN vs FOR Comparison

GERN vs FOR Comparison

Compare GERN & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.55

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Forestar Group Inc

FOR

Forestar Group Inc

HOLD

Current Price

$25.28

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GERN
FOR
Founded
1990
2005
Country
United States
United States
Employees
229
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
GERN
FOR
Price
$1.55
$25.28
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
$2.17
$31.75
AVG Volume (30 Days)
17.1M
105.0K
Earning Date
05-06-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.30
Revenue
N/A
$1,662,400,000.00
Revenue This Year
$26.91
$0.52
Revenue Next Year
$43.75
$7.72
P/E Ratio
N/A
$84.40
Revenue Growth
N/A
10.14
52 Week Low
$1.04
$18.00
52 Week High
$2.01
$30.74

Technical Indicators

Market Signals
Indicator
GERN
FOR
Relative Strength Index (RSI) 48.18 41.30
Support Level $1.24 $25.25
Resistance Level $1.70 $26.06
Average True Range (ATR) 0.10 0.75
MACD -0.01 0.01
Stochastic Oscillator 37.50 59.64

Price Performance

Historical Comparison
GERN
FOR

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. the company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

Share on Social Networks: